Recovering from head and neck cancer means addressing both physical and emotional needs. With the right care, compassion, and ...

About one-third of head and neck squamous cell cancer (HNSCC) survivors who have undergone radiation therapy (RT) are ...

Low-dose computed tomography is more sensitive than chest radiography in diagnosing lung metastases of second primary lung cancer in HNSCC survivors.

Phenotypic variables such as smoking history and occupational exposures were significators predictors of head and neck cancer risk.

First-line treatment with a Keytruda combo had an overall survival of 17.6 months in some with recurrent/metastatic head and ...

Unfortunately, despite the presence of early warning signs, many patients delay seeking medical care. As a result, a large number of head and neck cancers are not diagnosed until they have ...

Patients with locally advanced head and neck cancer who received the immune checkpoint inhibitor pembrolizumab before, during and after standard-of-care surgery had longer event-free survival without ...

For patients undergoing jaw reconstruction after surgery for head and neck cancer, computer-aided design and manufacturing (CAD/CAM) techniques can improve some key clinical outcomes, reports a study ...

Adding perioperative pembrolizumab to standard care can improve EFS in locally advanced head and neck cancer, data suggest.

FDA meeting requested following Phase IIb trial showing median overall survival of 17.6 months without chemotherapy Immutep ...

Adding pembrolizumab before and after surgery reduced recurrence and improved response in patients with locally advanced head ...